Asia Pacific Branched Stent Grafts Market Size & Outlook
Asia Pacific branched stent grafts market, 2021-2028 (US$M)
Related Markets
Asia Pacific branched stent grafts market highlights
- The Asia Pacific branched stent grafts market generated a revenue of USD 55.9 million in 2021.
- The market is expected to grow at a CAGR of 9.3% from 2022 to 2028.
- In terms of segment, iliac stent was the largest revenue generating type in 2021.
- Iliac Stent is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2022 to 2028.
Asia Pacific data book summary
| Market revenue in 2021 | USD 55.9 million |
| Market revenue in 2028 | USD 103.8 million |
| Growth rate | 9.3% (CAGR from 2021 to 2028) |
| Largest segment | Iliac stent |
| Fastest growing segment | Iliac Stent |
| Historical data covered | 2021 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iliac Stent |
| Key market players worldwide | Medtronic PLC, BIOTRONIK, Merit Medical Systems Inc, Abbott Laboratories, Cook Medical, Cardinal Health Inc, Boston Scientific Corp, Terumo Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.9% of the global branched stent grafts market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 103.8 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Branched Stent Grafts Market Scope
Branched Stent Grafts Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific branched stent grafts market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branched stent grafts market will help companies and investors design strategic landscapes.
Iliac stent was the largest segment with a revenue share of 38.46% in 2021. Horizon Databook has segmented the Asia Pacific branched stent grafts market based on iliac stent covering the revenue growth of each sub-segment from 2021 to 2028.
The Asia Pacific branched stent graft market is anticipated to hold market share of 19.88% in 2021 owing to rising spending on healthcare and growing medical tourism in the region.
Furthermore, increasing awareness among people in developing countries is boosting the demand for branched stent graft market. Australia has played a substantial part in the development of minimal image-guided therapy and technology for the management of aortic aneurysm disease.
Reasons to subscribe to Asia Pacific branched stent grafts market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific branched stent grafts market databook
-
Our clientele includes a mix of branched stent grafts market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific branched stent grafts market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific branched stent grafts market from 2021 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific branched stent grafts market size, by country, 2021-2028 (US$M)
Asia Pacific Branched Stent Grafts Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
